PAX5 and acute lymphoblastic leukemia: In summary, our detailed analysis of the Pax5Jak2/+ mouse model has identified the PAX5‐JAK2 rearrangement as a dual‐hit mutation that promotes B‐ALL development by maintaining high STAT5 activity in the nucleus.